CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Sales Revenue, Services, Net (Deprecated 2018-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $345.45 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-05-10
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $345.45M, a 13.44% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $337.66M, a 4.11% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $326.71M, a 11.56% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $329.40M, a 12.48% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $1.30B, a 14.82% increase from fiscal 2016.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $1.13B, a 31.75% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $858.24M, a 7.58% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $797.76M, a 15.76% increase from fiscal 2013.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $345.45M 10-Q · filed 2018-05-10 | $683.11M derived: sum of 2 quarters · filed 2018-05-10 | $1.01B derived: sum of 3 quarters · filed 2018-05-10 | $1.34B derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-12-30 | $337.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $664.37M derived: sum of 2 quarters · filed 2018-02-13 | $993.77M derived: sum of 3 quarters · filed 2018-02-13 | $1.30B 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $326.71M 10-Q · filed 2017-11-09 | $656.11M derived: sum of 2 quarters · filed 2017-11-09 | $960.64M 10-Q · filed 2017-11-09 | $1.28B derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-07-01 | $329.40M 10-Q · filed 2017-08-09 | $633.93M 10-Q · filed 2017-08-09 | $958.26M derived: sum of 3 quarters · filed 2018-05-10 | $1.25B derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-04-01 | $304.53M 10-Q · filed 2018-05-10 | $628.87M derived: sum of 2 quarters · filed 2018-05-10 | $921.72M derived: sum of 3 quarters · filed 2018-05-10 | $1.21B derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $324.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $617.18M derived: sum of 2 quarters · filed 2018-02-13 | $910.03M derived: sum of 3 quarters · filed 2018-02-13 | $1.13B 10-K · filed 2018-02-13 | |||
| 2016-09-24 | $292.85M 10-Q · filed 2017-11-09 | $585.70M derived: sum of 2 quarters · filed 2017-11-09 | $806.40M 10-Q · filed 2017-11-09 | $1.03B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-25 | $292.85M 10-Q · filed 2017-08-09 | $513.55M 10-Q · filed 2017-08-09 | $738.13M derived: sum of 3 quarters · filed 2018-02-13 | $960.63M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-26 | $220.70M 10-Q · filed 2017-05-10 | $445.28M derived: sum of 2 quarters · filed 2018-02-13 | $667.78M derived: sum of 3 quarters · filed 2018-02-13 | $882.16M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-26 | $224.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $447.08M derived: sum of 2 quarters · filed 2018-02-13 | $661.46M derived: sum of 3 quarters · filed 2018-02-13 | $858.24M 10-K · filed 2018-02-13 | |||
| 2015-09-26 | $222.51M 10-Q · filed 2016-11-02 | $436.89M derived: sum of 2 quarters · filed 2016-11-02 | $633.67M 10-Q · filed 2016-11-02 | $843.33M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-27 | $214.38M 10-Q · filed 2016-08-03 | $411.16M 10-Q · filed 2016-08-03 | $620.83M derived: sum of 3 quarters · filed 2017-02-14 | $825.58M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-28 | $196.78M 10-Q · filed 2016-05-04 | $406.45M derived: sum of 2 quarters · filed 2017-02-14 | $611.20M derived: sum of 3 quarters · filed 2017-02-14 | $822.20M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-27 | $209.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $414.42M derived: sum of 2 quarters · filed 2017-02-14 | $625.42M derived: sum of 3 quarters · filed 2017-02-14 | $797.76M 10-K · filed 2017-02-14 | |||
| 2014-09-27 | $204.75M 10-Q · filed 2015-11-04 | $415.75M derived: sum of 2 quarters · filed 2015-11-04 | $588.10M 10-Q · filed 2015-11-04 | $765.84M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-28 | $211.00M 10-Q · filed 2015-07-30 | $383.35M 10-Q · filed 2015-07-30 | $561.09M derived: sum of 3 quarters · filed 2016-02-12 | $736.49M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-29 | $172.34M 10-Q · filed 2015-04-30 | $350.09M derived: sum of 2 quarters · filed 2016-02-12 | $525.49M derived: sum of 3 quarters · filed 2016-02-12 | $696.56M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-28 | $177.74M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $353.14M derived: sum of 2 quarters · filed 2016-02-12 | $524.22M derived: sum of 3 quarters · filed 2016-02-12 | $689.17M 10-K · filed 2016-02-12 | |||
| 2013-09-28 | $175.40M 10-Q · filed 2014-10-30 | $346.47M derived: sum of 2 quarters · filed 2014-10-30 | $511.42M 10-Q · filed 2014-10-30 | $680.15M derived: sum of 4 quarters · filed 2014-10-30 | |||
| 2013-06-29 | $171.07M 10-Q · filed 2014-08-07 | $336.03M 10-Q · filed 2014-08-07 | $504.76M derived: sum of 3 quarters · filed 2014-08-07 | $672.25M derived: sum of 4 quarters · filed 2014-08-07 | |||
| 2013-03-30 | $164.95M 10-Q · filed 2014-04-30 | $333.68M derived: sum of 2 quarters · filed 2014-04-30 | $501.17M derived: sum of 3 quarters · filed 2014-04-30 | $666.77M derived: sum of 4 quarters · filed 2014-04-30 | |||
| 2012-12-29 | $168.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $336.22M derived: sum of 2 quarters · filed 2014-02-25 | $501.82M derived: sum of 3 quarters · filed 2014-02-25 | $661.59M 10-K · filed 2014-02-25 | |||
| 2012-09-29 | $167.49M 10-Q · filed 2013-10-30 | $333.09M derived: sum of 2 quarters · filed 2013-10-30 | $492.86M 10-Q · filed 2013-10-30 | $661.58M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $165.60M 10-Q · filed 2013-07-31 | $325.37M 10-Q · filed 2013-07-31 | $494.09M derived: sum of 3 quarters · filed 2014-02-25 | $654.73M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $159.77M 10-Q · filed 2013-05-08 | $328.49M derived: sum of 2 quarters · filed 2014-02-25 | $489.14M derived: sum of 3 quarters · filed 2014-02-25 | $654.66M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $168.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $329.37M derived: sum of 2 quarters · filed 2014-02-25 | $494.89M derived: sum of 3 quarters · filed 2014-02-25 | $659.34M 10-K · filed 2014-02-25 | |||
| 2011-09-24 | $160.65M 10-Q · filed 2012-11-01 | $326.17M derived: sum of 2 quarters · filed 2012-11-01 | $490.62M 10-Q · filed 2012-11-01 | $658.71M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-25 | $165.52M 10-Q · filed 2012-08-07 | $329.97M 10-Q · filed 2012-08-07 | $498.07M derived: sum of 3 quarters · filed 2013-02-27 | $660.27M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-26 | $164.45M 10-Q · filed 2012-05-04 | $332.54M derived: sum of 2 quarters · filed 2013-02-27 | $494.75M derived: sum of 3 quarters · filed 2013-02-27 | $668.00M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-25 | $168.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $330.30M derived: sum of 2 quarters · filed 2013-02-27 | $503.56M derived: sum of 3 quarters · filed 2013-02-27 | $674.79M 10-K · filed 2013-02-27 | |||
| 2010-09-25 | $162.20M 10-Q · filed 2011-11-02 | $167.40M 10-Q · filed 2010-11-04 | $335.46M derived: sum of 2 quarters · filed 2011-11-02 | $506.70M 10-Q · filed 2011-11-02 | $520.46M 10-Q · filed 2010-11-04 | $654.73M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-06-26 | $173.26M 10-Q · filed 2011-08-03 | $176.77M 10-Q · filed 2010-08-03 | $344.50M 10-Q · filed 2011-08-03 | $353.06M 10-Q · filed 2010-08-03 | $492.53M derived: sum of 3 quarters · filed 2012-02-27 | $676.57M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-03-27 | $171.24M 10-Q · filed 2011-05-04 | $319.27M derived: sum of 2 quarters · filed 2012-02-27 | $503.31M derived: sum of 3 quarters · filed 2012-02-27 | $692.99M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2009-12-26 | $148.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $332.07M derived: sum of 2 quarters · filed 2012-02-27 | $521.76M derived: sum of 3 quarters · filed 2012-02-27 | $706.37M 10-K · filed 2012-02-27 | |||
| 2009-09-26 | $184.04M 10-Q · filed 2010-11-04 | $373.73M derived: sum of 2 quarters · filed 2010-11-04 | $558.34M 10-Q · filed 2010-11-04 | ||||
| 2009-06-27 | $189.69M 10-Q · filed 2010-08-03 | $374.30M 10-Q · filed 2010-08-03 | |||||
| 2008-12-27 | $823.56M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |